Future scoring of ESPL1, PTTG1 and PTTG1IP transcript levels may be a helpful tool in risk stratification of CML patients before initiation of TKI first = line treatment. The gene discussed is PTTG1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.